33 results
424B3
INM
InMed Pharmaceuticals Inc.
27 Jun 24
Prospectus supplement
6:27pm
partnership(s) to advance the INM-755 program for the treatment of dermatological conditions including chronic itch;
continue to advance research … in another keratin called keratin 14, or “K14”. The anti-inflammatory activity of CBN may be beneficial in healing chronic wounds caused by prolonged
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc.
16 Apr 24
InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration
2:39pm
in the treatment of this chronic disease.”
Recent Preclinical Data
Data from a recent proof of concept study indicates that INM-089 may be more effective
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc.
13 Feb 24
InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update
7:34pm
believes that INM-755 holds promise for further advancement in the treatment of chronic itch and other related ailments. The Company is currently seeking
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc.
16 Jan 24
InMed Pharmaceuticals Provides Business Update and Milestones for 2024
2:12pm
of chronic itch and other related ailments and the Company is currently seeking partnerships for continued development. Due to several factors, including
8-K
EX-99.1
q2w a2uef
14 Nov 23
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
4:36pm
8-K
EX-99.1
ax4vjv3fk
29 Sep 23
InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update
5:18pm
8-K
EX-99.1
usd6xavw n20pjap
22 Jun 23
InMed Pharmaceuticals Inc. Announces Results from a Phase 2 Clinical Trial in Epidermolysis Bullosa
4:28pm
424B3
3o2efcloyb5zv6
6 Jul 22
Prospectus supplement
2:43pm
424B5
wm8r8efoi
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
8v21nsu0cc1qioby4
25 Apr 22
Prospectus supplement
5:02pm
424B3
kfna84b30ueag 5ss
7 Apr 22
Prospectus supplement
4:46pm
S-3
eyrkhdsds pqnyt9hr
4 Feb 22
Shelf registration
4:36pm
10-K
sra0wt46iqnrjz1k9d1
24 Sep 21
Annual report
7:31am